Dimensioni, segmenti e analisi del mercato delle immunoglobuline per via endovenosa in Nord America entro il 2023-2030
North America Intravenous Immunoglobulin Market: Strategic Insights
North America Intravenous Immunoglobulin Market
-
CAGR (2022 - 2030)7.1% -
Market Size 2022
US$ 5,042.91 Million -
Market Size 2030
US$ 8,747.81 Million

Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Takeda Pharmaceutical Co Ltd
- Grifols SA
- Pfizer Inc
- ADMA Biologics, Inc
- Bio Products Laboratory Ltd
- Octapharma AG
- Kedrion SpA
- CSL Ltd
- LFB Group
Regional Overview

- Nord America
Market Segmentation

- IgG
- IgA
- IgM

- Malattie da immunodeficienza
- Polineuropatia demielinizzante infiammatoria cronica
- Porpora trombocitopenica idiopatica
- Neuropatia motoria multifocale
- Ipogammaglobulinemia
- Sindrome di Guillain-Barré
- Deficit di anticorpi specifici
- Miopatie infiammatorie
- Miastenia grave

- farmacia ospedaliera
- farmacia al dettaglio

- ospedali
- cliniche specialistiche